Request Demo
Last update 23 Aug 2026
Shanghai Zhongze Pharmaceutical Technology Co., Ltd
Last update 23 Aug 2026
Overview
Tags
Nervous System Diseases
Other Diseases
Endocrinology and Metabolic Disease
Small molecule drug
Chemical drugs
Synthetic peptide
Disease domain score
A glimpse into the focused therapeutic areas
Technology Platform
Most used technologies in drug development
Targets
Most frequently developed targets
Related
Target |
Mechanism |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest Phase |
First Approval Ctry. / Loc. |
First Approval Date |
Target |
Mechanism |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest Phase |
First Approval Ctry. / Loc. |
First Approval Date |
Target |
Mechanism |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication |
Drug Highest Phase |
First Approval Ctry. / Loc. |
First Approval Date |
NCT07626034
An Open-label Positron Emission Tomography (PET) Study to Evaluate Brain Dopamine D2 and D3 Receptor Occupancy by SIPI6398 in Healthy Volunteers and Patients With Schizophrenia
CTR20253241
多中心、随机、双盲双模拟、阳性药和安慰剂平行对照IIb期临床研究，评估SIPI6398片在急性精神分裂症患者中的有效性和安全性
[Translation] A multicenter, randomized, double-blind, double-dummy, active and placebo-controlled Phase IIb clinical study to evaluate the efficacy and safety of SIPI6398 tablets in patients with acute schizophrenia.
CTR20251117
多中心、随机、双盲、安慰剂平行对照、剂量探索的Ⅱ期临床研究，初步评价SIPI6398片用于抑郁症患者的有效性和安全性
[Translation] A multicenter, randomized, double-blind, placebo-controlled, dose-finding Phase II clinical study to preliminarily evaluate the efficacy and safety of SIPI6398 tablets in patients with depression
100 Clinical Results associated with Shanghai Zhongze Pharmaceutical Technology Co., Ltd
Login to view more data
Login to view more data
100 Deals associated with Shanghai Zhongze Pharmaceutical Technology Co., Ltd
Login to view more data
100 Translational Medicine associated with Shanghai Zhongze Pharmaceutical Technology Co., Ltd
Login to view more data
Corporation Tree
Boost your research with our corporation tree data.
login
or
Pipeline
Pipeline Snapshot as of 31 Aug 2026
The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3
Discovery
3
1
Phase 1
Phase 2
2
1
Other
Login to view more data
Current Projects
Login to view more data
Deal
Boost your decision using our deal data.
login
or
Translational Medicine
Boost your research with our translational medicine data.
login
or
Profit
Explore the financial positions of over 360K organizations with Synapse.
login
or
Grant & Funding(NIH)
Access more than 2 million grant and funding information to elevate your research journey.
login
or
Investment
Gain insights on the latest company investments from start-ups to established corporations.
login
or
Financing
Unearth financing trends to validate and advance investment opportunities.
login
or
Hiro LS Researcher
The AI Search Engine Built to Accelerate Biopharma Decisions
Search across billion-scale life sciences data to uncover signals, validate evidence, and act with confidence.
Ask any biopharma research question→
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, Patsnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Discover Synapse Data Servers
Synapse data is now integrated into the PatSnap LS Model Context Protocol (MCP) service. Customize your LLM agent now using our MCP server!
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free